Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bitartrate, Prajmaline
2. Bitartrate, Prajmalium
3. N-propylajmaline
4. Neo Gilurytmal
5. Neo-gilurytmal
6. Neogilurytmal
7. Prajmaline Bitartrate
8. Prajmalium
9. Prajmalium Bitartrate
1. Prajmalium
2. N-propylajmaline
3. 35080-11-6
4. 75934ud4gj
5. Ajmalanium, 17,21-dihydroxy-4-propyl-, (17r,21-alpha)-
6. N-propylajmalinium
7. Prajmalium Ion
8. Prajmalium Cation
9. Prajmalum
10. N(sup 4)-propylajmalinium
11. Unii-75934ud4gj
12. Prajmaline [mi]
13. Prajmalium [who-dd]
14. (17r,21-alpha)-17,21-dihydroxy-4-propylajmalanium
15. Chebi:135560
16. Zinc252462538
17. Db13555
18. Q7238143
19. Ajmalanine, 17,21-dihydroxy-4-propyl-, (17r,21.alpha.)-
20. (1r,9r,10s,12r,13s,14r,15r,16s,17s,18r)-13-ethyl-8-methyl-15-propyl-8-aza-15-azoniahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol
Molecular Weight | 369.5 g/mol |
---|---|
Molecular Formula | C23H33N2O2+ |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 369.254203300 g/mol |
Monoisotopic Mass | 369.254203300 g/mol |
Topological Polar Surface Area | 43.7 Ų |
Heavy Atom Count | 27 |
Formal Charge | 1 |
Complexity | 642 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
C - Cardiovascular system
C01 - Cardiac therapy
C01B - Antiarrhythmics, class i and iii
C01BA - Antiarrhythmics, class ia
C01BA08 - Prajmaline
ABOUT THIS PAGE
A Prajmaline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prajmaline, including repackagers and relabelers. The FDA regulates Prajmaline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prajmaline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Prajmaline supplier is an individual or a company that provides Prajmaline active pharmaceutical ingredient (API) or Prajmaline finished formulations upon request. The Prajmaline suppliers may include Prajmaline API manufacturers, exporters, distributors and traders.
Prajmaline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prajmaline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prajmaline GMP manufacturer or Prajmaline GMP API supplier for your needs.
A Prajmaline CoA (Certificate of Analysis) is a formal document that attests to Prajmaline's compliance with Prajmaline specifications and serves as a tool for batch-level quality control.
Prajmaline CoA mostly includes findings from lab analyses of a specific batch. For each Prajmaline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prajmaline may be tested according to a variety of international standards, such as European Pharmacopoeia (Prajmaline EP), Prajmaline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prajmaline USP).
LOOKING FOR A SUPPLIER?